Pharmapack Europe integral to anti-counterfeiting efforts Serialisation, track & trace at the top of the agenda in Europe’s biggest packaging show

Mar 21, 2016

  Paris, 21 March 2016: Pharmapack Europe (#pharmapackeu), organised by UBM EMEA, held its most successful event yet at the Paris expo Porte De Versailles on the 10th and 11th of February 2016. The event, exclusively dedicated to the pharma packaging and drug delivery industry, gathered 3409 visitors and 387 exhibitors under one roof – an increase from 2015 of 12% and 15% respectively. Moreover, 70% of the exhibitors were international, with high-level representatives from 74 countries ready to discuss the industry’s most pressing issues and present innovative solutions.   Chief among the event’s themes was serialisation and the industry’s efforts to overcome counterfeiting ...

Read More

Growth in Finished Dosage Formulations sees CPhI Worldwide introduce new event 

Feb 17, 2016

Expanding its reputation as a global hub for the final dose supply chain is a key strategy for CPhI in 2016 Amsterdam, 16 February 2016: CPhI Worldwide, organised by UBM EMEA, formally introduces a new co-located event entirely dedicated to Finished Dosage Formulation (FDF) following a soft launch amongst exhibitors in 2015. This new event will open at the 27th CPhI Worldwide in Barcelona (4-6 October 2016) and reflects the huge growth in finished dosage formulations across the wider pharma market. The next stage in the pharma event’s introduction is to target new potential visitors and attendees through a sustained marketing and branding effort.   ...

Read More

Aptar Stelmi features PremiumCoat™ at CPhI/InnoPack 2015, from 13-15 October, in Madrid, Spain

Oct 9, 2015

Coated stoppers for sensitive and high-value injectables     Aptar Stelmi, the industry’s trusted global partner, providing premium elastomeric closure systems for injectables, announces a new addition to its broad portfolio of products with the introduction of a novel range of coated stoppers calledPremiumCoat™, designed for the protection of sensitive and high-value drugs, including biopharmaceuticals.   Sensitive and high-value injectables, a dynamic market   Sensitive and high-value injectables encompass complex and potent drugs manufactured by chemical synthesis and biological agents engineered in a living system such as a microorganism, plant or animal cell. They include cytotoxic drugs used in cancer ...

Read More